Compared with CON-IgG, NMO-IgG induces the significant release of several chemokines and cytokines, including CCL2, CXCL1, IL-1β, IL-17A, IL-18, and IL-6 (Figure 3E) (p < 0.05). The gene discussed is CXCL1; the disease is neuromyelitis optica.